---
title: "Kangxin New Materials released its first-quarter performance, with a net loss attributable to the parent company of 45.5071 million yuan, an expanded loss"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237691323.md"
description: "According to the Zhitong Finance APP, Kangxin New Materials released its Q1 2025 report, with the company's Q1 operating revenue at 57.2125 million yuan, a year-on-year increase of 8.96%; the net loss attributable to shareholders of the listed company was 45.5071 million yuan, an expanded loss; the net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 47.0046 million yuan, an expanded loss; the basic loss per share was 0.03 yuan/share"
datetime: "2025-04-27T08:16:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237691323.md)
  - [en](https://longbridge.com/en/news/237691323.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237691323.md)
generator: "portal-rs"
---

# Kangxin New Materials released its first-quarter performance, with a net loss attributable to the parent company of 45.5071 million yuan, an expanded loss

According to the Zhitong Finance APP, Kangxin New Materials (600076.SH) released its first-quarter report for 2025. The company's operating revenue in the first quarter was 57.2125 million yuan, a year-on-year increase of 8.96%; the net loss attributable to shareholders of the listed company was 45.5071 million yuan, an expanded loss; the net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 47.0046 million yuan, an expanded loss; the basic loss per share was 0.03 yuan/share

### Related Stocks

- [600076.CN](https://longbridge.com/en/quote/600076.CN.md)

## Related News & Research

- [Asia Naphtha/Gasoline-Naphtha prices rise mirroring crude gains](https://longbridge.com/en/news/298443702.md)
- [FDA Approves Tablet Form of Zanubrutinib for All Approved Indications](https://longbridge.com/en/news/298434766.md)
- [US Cocoa Futures (COCOA-F) Is down 2.04% on Sep 10: Here Is Why](https://longbridge.com/en/news/298575877.md)
- [Atrys Health Accelerates Growth and Slashes Debt in First Half of 2026](https://longbridge.com/en/news/298692631.md)
- [Health Rounds: Experimental eye drops ease night vision problems for drivers](https://longbridge.com/en/news/298635688.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**